首页> 外国专利> TARGETING APTAMER FOR ATHEROSCLEROSIS AND PREPARATION METHOD AND APPLICATION THEREOF

TARGETING APTAMER FOR ATHEROSCLEROSIS AND PREPARATION METHOD AND APPLICATION THEREOF

机译:动脉粥样硬化的靶向剂及其制备方法和应用

摘要

Disclosed are a targeting aptamer for atherosclerosis and a preparation method and application thereof. The targeting aptamer is a targeting aptamer fragment for atherosclerosis obtained through screening of macrophage-derived foam cells together with reverse screening of smooth muscle cells, endothelial cells, and THP-1 cells using a SELEX method; and the use of the targeting aptamer in preparation of an MRI targeting nano-contrast agent for atherosclerosis allows the specific binding of the MRI targeting nano-contrast agent for atherosclerosis only with the macrophage-derived foam cells, and allows high specific binding thereof with vascular tissues with AS lesion, thus improving targeting effect of the MRI targeting nano-contrast agent for atherosclerosis and realizing early specific diagnosis of arterial sclerosis.
机译:本发明公开了一种用于动脉粥样硬化的靶向适体及其制备方法和应用。靶向适体是用于动脉粥样硬化的靶向适体片段,其通过使用SELEX方法筛选巨噬细胞衍生的泡沫细胞并反向筛选平滑肌细胞,内皮细胞和THP-1细胞而获得。以及所述靶向适体在制备用于动脉粥样硬化的MRI靶向纳米造影剂中的用途使得所述MRI靶向纳米造影剂用于动脉粥样硬化仅与巨噬细胞衍生的泡沫细胞特异性结合,并且允许其与血管的高特异性结合具有AS病变的组织,从而提高了MRI靶向纳米造影剂对动脉粥样硬化的靶向作用,并实现了动脉硬化的早期特异性诊断。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号